Target intelligence / Profile preview

Ribosomal protein L17 pseudogene 20 (RPL17P20)

Target
RPL17P20
Molecular classification
Other (Pseudogene; derived from ribosomal protein gene family)
01

Overview

Ribosomal protein L17 pseudogene 20 (RPL17P20) is a processed pseudogene found in the human genome. It is derived from the ribosomal protein L17 gene, which encodes a component of the large 60S subunit of the ribosome involved in protein synthesis[1][5]. Unlike the functional RPL17 gene, RPL17P20 does not code for a protein and is generally considered biologically inactive. Pseudogenes like RPL17P20 arise from duplication or retrotransposition events; mutations or deletions render them non-functional. While some ribosomal pseudogenes may have regulatory potential under specific circumstances, there is no evidence supporting a pharmacological or diagnostic role for RPL17P20[1][4][7][8].

Other names
RPL17P20RPL17_10_481
02

Biological functions

Other (No known biological function; pseudogenes are generally nonfunctional due to genetic mutations/disruption)
03

Disease associations

Other (No well-established direct disease association; ribosomal protein pseudogenes as a class are not considered pathogenic)

Beyond the preview

Go deeper on Ribosomal protein L17 pseudogene 20 (RPL17P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L17 pseudogene 20 (RPL17P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call